Adding vitamin B12 may help reduce certain side effects, like fatigue, for some people
Every fat-metabolism, NAD+, SIRT1 and lean-mass effect described above is preclinical (rodent or cell) only and should be read as a hypothesis, not an established human benefit
No receptor downregulation: Unlike some fat burners that lose effectiveness as your body adapts, AOD 9604 doesn't cause significant receptor desensitization
Understanding the appropriate dosage and administration method is vital for effective treatment
Clinical trials of AOD-9604 lasting up to 24 weeks demonstrated no cardiovascular adverse events and excellent overall tolerability
Low dietary calcium intakes and increased circulating VD 3 may also have indirect inhibitory effects on adipocyte lipolysis by regulating the use of lipolytic substrates for energy metabolism (111, 122)